![Comparison of Contrast Enhanced MDCT and Integrated FDG PET/CT Staging of Colorectal Cancer | Insight Medical Publishing Comparison of Contrast Enhanced MDCT and Integrated FDG PET/CT Staging of Colorectal Cancer | Insight Medical Publishing](https://colorectal-cancer.imedpub.com/articles-images/Colorectal-Cancer-altered-bowel-habits-2-2-10-g002.png)
Comparison of Contrast Enhanced MDCT and Integrated FDG PET/CT Staging of Colorectal Cancer | Insight Medical Publishing
Evaluation of Relapse-Free Survival in T3N0 Colon Cancer: The Role of Chemotherapy, a Multicentric Retrospective Analysis | PLOS ONE
![Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer](https://www.frontiersin.org/files/Articles/977652/fmed-09-977652-HTML/image_m/fmed-09-977652-g003.jpg)
Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer
![Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer](https://www.frontiersin.org/files/Articles/977652/fmed-09-977652-HTML/image_m/fmed-09-977652-g001.jpg)
Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer
![3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive 3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive](https://www.snfge.org/sites/www.snfge.org/files/SNFGE/TNCD/tncd_chap-03_figure-4.png)
3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
![Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer](https://www.frontiersin.org/files/Articles/977652/fmed-09-977652-HTML/image_m/fmed-09-977652-g002.jpg)
Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer
![TNM Staging of Colorectal Cancer Should be Reconsidered According to Weighting of the T Stage: Verification Based on a 25-Year Follow-Up. - Abstract - Europe PMC TNM Staging of Colorectal Cancer Should be Reconsidered According to Weighting of the T Stage: Verification Based on a 25-Year Follow-Up. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4753906/bin/medi-95-e2711-g001.jpg)
TNM Staging of Colorectal Cancer Should be Reconsidered According to Weighting of the T Stage: Verification Based on a 25-Year Follow-Up. - Abstract - Europe PMC
![Should mismatch repair status be determined in all stage II and III colon cancer patients? | Colorectal Cancer Should mismatch repair status be determined in all stage II and III colon cancer patients? | Colorectal Cancer](https://www.futuremedicine.com/cms/10.2217/crc.14.25/asset/images/medium/figure2.gif)
Should mismatch repair status be determined in all stage II and III colon cancer patients? | Colorectal Cancer
Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis,International Journal of Colorectal Disease - X-MOL
![Serosal surfaces, mucin pools, and deposits, Oh my: challenges in staging colorectal carcinoma | Modern Pathology Serosal surfaces, mucin pools, and deposits, Oh my: challenges in staging colorectal carcinoma | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2014.128/MediaObjects/41379_2015_Article_BFmodpathol2014128_Fig1_HTML.jpg)
Serosal surfaces, mucin pools, and deposits, Oh my: challenges in staging colorectal carcinoma | Modern Pathology
![Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients | Radiation Oncology | Full Text Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-020-01497-4/MediaObjects/13014_2020_1497_Fig1_HTML.png)
Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients | Radiation Oncology | Full Text
![Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database - ScienceDirect Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1743919116302825-gr3.jpg)
Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database - ScienceDirect
![Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer Frontiers | A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer](https://www.frontiersin.org/files/MyHome%20Article%20Library/977652/977652_Thumb_400.jpg)